US5260421A
(en)
*
|
1987-12-21 |
1993-11-09 |
Applied Research Systems Ars Holding N.V. |
Site-directed mutagenesis modified glycoprotein hormones
|
US5705478A
(en)
*
|
1989-02-21 |
1998-01-06 |
Washington University |
Covalently linked β subunits of the glycoprotein hormones as antagonists
|
US5792460A
(en)
*
|
1989-02-21 |
1998-08-11 |
Washington University |
Modified glycoprotein hormones having a CTP at the amino terminus
|
US6225449B1
(en)
*
|
1991-10-04 |
2001-05-01 |
Washington University |
Hormone analogs with multiple CTP extensions
|
US5240832A
(en)
*
|
1989-06-20 |
1993-08-31 |
Genzyme Corporation |
Heteropolymeric protein production methods
|
WO1992022568A1
(fr)
*
|
1991-06-18 |
1992-12-23 |
University Of Medicine & Dentistry Of New Jersey |
Analogues des hormones glycoproteiques presentant une specificite et une activite de liaison avec les recepteurs modifiees, et procedes de preparation et d'utilisation de ces analogues
|
US6028177A
(en)
*
|
1991-10-04 |
2000-02-22 |
Washington University |
Methods of detecting single-chain forms of the glycoprotein hormone quartet
|
US5985611A
(en)
*
|
1992-04-30 |
1999-11-16 |
Washington University |
Recombinant production of gonadotropins in secretory cells
|
JP4156024B2
(ja)
*
|
1993-04-20 |
2008-09-24 |
ワシントン ユニバーシティー |
修飾されたタンパク質及びペプチド医薬品
|
US5643745A
(en)
*
|
1994-02-03 |
1997-07-01 |
University Of Hawaii |
Heterologous dimeric proteins produced in heterokaryons
|
US5683899A
(en)
*
|
1994-02-03 |
1997-11-04 |
University Of Hawaii |
Methods and compositions for combinatorial-based discovery of new multimeric molecules
|
US6238890B1
(en)
|
1994-02-18 |
2001-05-29 |
Washington University |
Single chain forms of the glycoprotein hormone quartet
|
GB9403600D0
(en)
*
|
1994-02-24 |
1994-04-13 |
Univ Glasgow |
Three dimensional hormone structure
|
WO1995032216A1
(fr)
*
|
1994-05-25 |
1995-11-30 |
University Of Nebraska Board Of Regents |
Hormones glycoproteiques biologiquement actives produites dans des cellules procaryotes
|
BR9506313A
(pt)
*
|
1994-08-12 |
1997-08-05 |
Univ Washington |
Formas de cadeia simples do quarteto de hormônio de glicoproteína
|
CA2173750C
(fr)
*
|
1994-08-12 |
2011-03-22 |
Irving Boime |
Formes monocatenaires du quadruplet d'hormones de glycoproteine
|
US5733735A
(en)
*
|
1996-06-11 |
1998-03-31 |
Washington University |
Assay system to determine receptor antagonist target site
|
TW518235B
(en)
*
|
1997-01-15 |
2003-01-21 |
Akzo Nobel Nv |
A gonadotropin-containing pharmaceutical composition with improved stability on prolong storage
|
US5883073A
(en)
*
|
1997-04-03 |
1999-03-16 |
Washington University |
Single-chain double-alpha peptide
|
KR100642602B1
(ko)
*
|
1997-09-22 |
2006-11-10 |
유니버시티 어브 메릴랜드, 발티모어 |
갑상선자극호르몬의 돌연변이 및 그에 근거한 방법
|
US6103501A
(en)
*
|
1997-11-17 |
2000-08-15 |
Washington University |
Single chain glycoprotein hormones comprising two β and one α subunits and recombinant production thereof
|
US6635256B1
(en)
|
1998-10-19 |
2003-10-21 |
Washington University |
Glycoprotein hormone compositions comprising two β subunits and methods of use thereof
|
CN1317967A
(zh)
|
1998-09-17 |
2001-10-17 |
伊莱利利公司 |
蛋白质制剂
|
AU779869B2
(en)
|
1999-04-13 |
2005-02-17 |
Nektar Therapeutics |
Pulmonary administration of dry powder formulations for treating infertility
|
EP1257564B1
(fr)
*
|
2000-02-22 |
2008-08-27 |
Laboratoires Serono SA |
Procede pour la purification de la hcg purifiee recombinante ayant une bioactivite specifique
|
RS50416B
(sr)
*
|
2000-02-22 |
2009-12-31 |
Laboratoires Serono Sa., |
Prečišćeni lh
|
US7514239B2
(en)
*
|
2000-03-28 |
2009-04-07 |
Amgen Inc. |
Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptides and heterodimers thereof
|
JP2001333772A
(ja)
|
2000-04-25 |
2001-12-04 |
Washington Univ |
可変性の活性を有する単鎖稔性ホルモン
|
US20040005554A1
(en)
*
|
2000-05-08 |
2004-01-08 |
Tayar Nabil El |
Novel glycoproteins and methods of use thereof
|
US6493964B1
(en)
|
2000-05-25 |
2002-12-17 |
Tousimis Research Corp. |
Supercritical point drying apparatus for semiconductor device manufacturing and bio-medical sample processing
|
KR101229995B1
(ko)
*
|
2000-12-11 |
2013-02-06 |
씨제이 주식회사 |
생체내 에리스로포이에틴 활성이 증진된 융합단백질
|
DE60117919T2
(de)
*
|
2000-12-11 |
2006-12-14 |
Cheil Jedang Corp. |
Fusionsprotein mit verbesserter in vivo erythropoietinwirkung
|
US6987172B2
(en)
|
2001-03-05 |
2006-01-17 |
Washington University In St. Louis |
Multifunctional single chain glycoprotein hormones comprising three or more β subunits
|
US6573237B2
(en)
|
2001-03-16 |
2003-06-03 |
Eli Lilly And Company |
Protein formulations
|
PL373566A1
(en)
*
|
2001-11-08 |
2005-09-05 |
William R. Moyle |
Protein knobs
|
KR100467750B1
(ko)
*
|
2001-11-29 |
2005-01-24 |
씨제이 주식회사 |
생체내 에리스로포이에틴 활성이 증진된 융합단백질
|
KR100467751B1
(ko)
*
|
2001-12-03 |
2005-01-24 |
씨제이 주식회사 |
생체내 에리스로포이에틴 활성이 증진된 융합단백질
|
US7081446B2
(en)
*
|
2002-01-31 |
2006-07-25 |
The Trustees Of Columbia University In The City Of New York |
Long-acting follicle stimulating hormone analogues and uses thereof
|
US7173113B2
(en)
*
|
2002-01-31 |
2007-02-06 |
The Trustees Of Columbia University In The City Of New York |
Long-acting hormone and growth factor compositions and uses thereof
|
US20050256035A1
(en)
*
|
2002-05-13 |
2005-11-17 |
Irving Boime |
Ctp-extended erythropoietin
|
US20060177894A1
(en)
*
|
2002-11-08 |
2006-08-10 |
Moyle William R |
Protein knobs
|
EP1610803B8
(fr)
|
2003-03-04 |
2011-09-14 |
AspenBio Pharma, Inc. |
LH pour utilisation pour maintenir une ou plusieurs grossesses en induisant la formation du corps jaune secondaire.
|
DE602004006286T2
(de)
*
|
2003-07-25 |
2008-01-03 |
Laboratoires Serono S.A. |
Verwendung des follikel stimulierenden hormons zur reduzierung von chromosomalen aberrationen der spermatozoen in mann
|
UA88879C2
(en)
*
|
2003-09-02 |
2009-12-10 |
Эплайд Рисерч Системз Эрс Холдинг Н.В. |
Fsh glycosylation mutant
|
WO2005044851A1
(fr)
*
|
2003-11-06 |
2005-05-19 |
Compugen Ltd. |
Variants de la chaine alpha de l'hormone glycoproteine humaine, compositions et utilisations associees
|
JP4412989B2
(ja)
*
|
2003-12-15 |
2010-02-10 |
株式会社日立製作所 |
複数の記憶システムを有するデータ処理システム
|
US20050220640A1
(en)
*
|
2004-04-02 |
2005-10-06 |
Finkenbinder David B |
Fan motor assembly with noise suppression
|
JP2008508294A
(ja)
*
|
2004-07-27 |
2008-03-21 |
ジェンザイム・コーポレイション |
骨の再生のためのチロトロピンの使用法
|
NZ556726A
(en)
*
|
2005-01-25 |
2011-04-29 |
Cell Therapeutics Inc |
Conjugates of biologically active proteins having a modified in vivo half-life
|
US20080039372A1
(en)
*
|
2005-07-21 |
2008-02-14 |
The Trustees Of Columbia University In The City Of New York |
Human chorionic gonadotropin antagonists and methods to prevent ovarian hyperstimulation
|
SG155183A1
(en)
*
|
2005-08-26 |
2009-09-30 |
Ares Trading Sa |
Process for the preparation of glycosylated interferon beta
|
AU2006323925B2
(en)
*
|
2005-12-09 |
2012-08-02 |
Ares Trading S.A. |
Method for purifying FSH or a FSH mutant
|
US20150038413A1
(en)
|
2006-02-03 |
2015-02-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US10351615B2
(en)
|
2006-02-03 |
2019-07-16 |
Opko Biologics Ltd. |
Methods of treatment with long-acting growth hormone
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US20140113860A1
(en)
|
2006-02-03 |
2014-04-24 |
Prolor Biotech Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8048848B2
(en)
|
2006-02-03 |
2011-11-01 |
Prolor Biotech Ltd. |
Long-acting interferons and derivatives thereof and methods thereof
|
US9249407B2
(en)
|
2006-02-03 |
2016-02-02 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US10221228B2
(en)
|
2006-02-03 |
2019-03-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
US7553940B2
(en)
|
2006-02-03 |
2009-06-30 |
Modigene Inc |
Long-acting EPO polypeptides and derivatives thereof and methods thereof
|
US8304386B2
(en)
*
|
2006-02-03 |
2012-11-06 |
Prolor Biotech, Inc. |
Long-acting growth hormone and methods of producing same
|
US8450269B2
(en)
|
2006-02-03 |
2013-05-28 |
Prolor Biotech Ltd. |
Long-acting growth hormone and methods of producing same
|
US8759292B2
(en)
|
2006-02-03 |
2014-06-24 |
Prolor Biotech, Llc |
Long-acting coagulation factors and methods of producing same
|
US8048849B2
(en)
|
2006-02-03 |
2011-11-01 |
Modigene, Inc. |
Long-acting polypeptides and methods of producing same
|
US20070281883A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Hanna Rosenfeld |
Development of follicle stimulating hormone agonists and antagonists in fish
|
US20100256337A1
(en)
*
|
2007-10-22 |
2010-10-07 |
Merck Serono Sa |
Method for purifying an fc-containing protein
|
JP2011500756A
(ja)
*
|
2007-10-22 |
2011-01-06 |
メルク セローノ ソシエテ アノニム |
Fc融合タンパク質を精製する方法
|
US9663778B2
(en)
|
2009-07-09 |
2017-05-30 |
OPKO Biologies Ltd. |
Long-acting coagulation factors and methods of producing same
|
AU2010290131C1
(en)
|
2009-08-24 |
2015-12-03 |
Amunix Operating Inc. |
Coagulation factor VII compositions and methods of making and using same
|
AR081755A1
(es)
|
2010-04-02 |
2012-10-17 |
Hanmi Holdings Co Ltd |
Formulacion de accion prolongada de la hormona estimuladora de los foliculos donde se usa un fragmento de inmunoglobulina, metodo de preparacion y metodo para tratar a un sujeto que sufre un trastorno reproductivo
|
SI2717898T1
(sl)
|
2011-06-10 |
2019-07-31 |
Bioverativ Therapeutics Inc. |
Spojine prokoagulantov in metode za njihovo uporabo
|
ES2722209T3
(es)
|
2011-07-08 |
2019-08-08 |
Bioverativ Therapeutics Inc |
Polipéptidos quiméricos e híbridos del Factor VIII, y métodos de uso de los mismos
|
EP2734239A2
(fr)
|
2011-07-18 |
2014-05-28 |
Arts Biologics A/S |
Composé hormone lutéinisante (lh) biologiquement actif à longue action
|
KR102310704B1
(ko)
|
2012-02-14 |
2021-10-08 |
옵코 바이오로직스 리미티드 |
장기 작용 응고 인자들 및 이를 생산하는 방법들
|
SI3564260T1
(sl)
|
2012-02-15 |
2023-02-28 |
Bioverativ Therapeutics Inc. |
Sestavki faktorja VIII in postopki njegove izdelave in uporabe
|
CA2864126A1
(fr)
|
2012-02-15 |
2013-08-22 |
Biogen Idec Ma Inc. |
Proteines de facteur viii de recombinaison
|
PE20142405A1
(es)
|
2012-04-19 |
2015-01-25 |
Opko Biolog Ltd |
Variantes de oxintomodulina de accion prolongada y metodos de produccion de las mismas
|
AU2013270683A1
(en)
|
2012-06-08 |
2014-12-11 |
Biogen Ma Inc. |
Chimeric clotting factors
|
EP3693000B1
(fr)
|
2012-06-08 |
2022-03-02 |
Bioverativ Therapeutics Inc. |
Composés procoagulants
|
EP2870250B2
(fr)
|
2012-07-06 |
2022-06-29 |
Bioverativ Therapeutics Inc. |
Lignée cellulaire exprimant des polypeptides de facteur viii à une seule chaîne et ses utilisations
|
CA2888806A1
(fr)
|
2012-10-18 |
2014-04-24 |
Biogen Idec Ma Inc. |
Procedes d'utilisation d'une dose fixe d'un facteur de coagulation
|
EP3943102A1
(fr)
|
2012-10-30 |
2022-01-26 |
Bioverativ Therapeutics Inc. |
Procédé d'utilisation de polypeptide du facteur viii
|
SG10202010383YA
(en)
|
2012-11-20 |
2020-11-27 |
Opko Biologics Ltd |
Method of increasing the hydrodynamic volume of polypeptides by attaching to gonadotrophin carboxy terminal peptides
|
CN103509121B
(zh)
|
2012-11-22 |
2015-01-28 |
苏州康宁杰瑞生物科技有限公司 |
一种fsh融合蛋白及其制备方法和用途
|
US9707276B2
(en)
|
2012-12-03 |
2017-07-18 |
Merck Sharp & Dohme Corp. |
O-glycosylated carboxy terminal portion (CTP) peptide-based insulin and insulin analogues
|
HRP20231183T1
(hr)
|
2013-02-15 |
2024-01-05 |
Bioverativ Therapeutics Inc. |
Optimizirani gen faktora viii
|
EP2968391A1
(fr)
|
2013-03-13 |
2016-01-20 |
Moderna Therapeutics, Inc. |
Molécules polynucléotidiques à longue durée de vie
|
TWI629993B
(zh)
|
2013-03-15 |
2018-07-21 |
美商生物化學醫療公司 |
因子viii多肽調配物
|
TWI788044B
(zh)
|
2013-03-15 |
2022-12-21 |
美商百歐維拉提夫治療公司 |
因子ix多肽調配物
|
EP3033097B1
(fr)
|
2013-08-14 |
2021-03-10 |
Bioverativ Therapeutics Inc. |
Fusions de factor viii-xten et leurs utilisations.
|
EP4108254A1
(fr)
|
2013-08-14 |
2022-12-28 |
Bioverativ Therapeutics Inc. |
Protéines de facteur viii de recombinaison
|
KR20160068969A
(ko)
|
2013-10-21 |
2016-06-15 |
옵코 바이오로직스 리미티드 |
장시간-작용하는 폴리펩티드, 그의 생산 방법, 및 그의 투여 방법
|
US20150158926A1
(en)
|
2013-10-21 |
2015-06-11 |
Opko Biologics, Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
CN103539860B
(zh)
*
|
2013-11-01 |
2014-12-03 |
广州优联康医药科技有限公司 |
一种长效重组人促卵泡激素融合蛋白
|
WO2015070014A1
(fr)
|
2013-11-08 |
2015-05-14 |
Biogen Idec Ma Inc. |
Composé de fusion procoagulant
|
ES2967617T3
(es)
|
2013-12-06 |
2024-05-03 |
Bioverativ Therapeutics Inc |
Herramientas de farmacocinética poblacional y sus usos
|
AU2015236340B2
(en)
|
2014-03-24 |
2020-02-06 |
Bioverativ Therapeutics Inc. |
Lyophilized factor IX formulations
|
WO2016004113A1
(fr)
|
2014-06-30 |
2016-01-07 |
Biogen Ma Inc. |
Gène du facteur ix optimisé
|
PL3207130T3
(pl)
|
2014-10-14 |
2020-02-28 |
Halozyme, Inc. |
Kompozycje deaminazy adenozyny 2 (ada2), jej warianty i sposoby ich zastosowania
|
MA40835A
(fr)
|
2014-10-23 |
2017-08-29 |
Biogen Ma Inc |
Anticorps anti-gpiib/iiia et leurs utilisations
|
MA40861A
(fr)
|
2014-10-31 |
2017-09-05 |
Biogen Ma Inc |
Anticorps anti-glycoprotéines iib/iiia
|
RU2021103436A
(ru)
|
2014-12-10 |
2021-02-25 |
Опко Байолоджикс Лтд. |
Способы производства ctp-модифицированных полипептидов гормона роста длительного действия
|
CN108289851B
(zh)
|
2015-06-19 |
2021-06-01 |
Opko生物科学有限公司 |
长效凝固因子及其产生方法
|
CN108472337B
(zh)
|
2015-08-03 |
2022-11-25 |
比奥贝拉蒂治疗公司 |
因子ix融合蛋白以及其制备和使用方法
|
HRP20221089T1
(hr)
|
2016-02-01 |
2022-11-25 |
Bioverativ Therapeutics Inc. |
Optimizirani geni faktora viii
|
KR20240006077A
(ko)
|
2016-07-11 |
2024-01-12 |
옵코 바이오로직스 리미티드 |
지속성 응고 인자 vii 및 그 제조 방법
|
KR20190091292A
(ko)
|
2016-12-02 |
2019-08-05 |
바이오버라티브 테라퓨틱스 인크. |
응고 인자에 대한 면역 내성 유도 방법
|
IL308416A
(en)
|
2016-12-02 |
2024-01-01 |
Bioverativ Therapeutics Inc |
Methods for the treatment of hemophilic arthritis with the help of chimeric blood coagulation factors
|
WO2018112362A1
(fr)
|
2016-12-16 |
2018-06-21 |
Biogen Ma Inc. |
Facteur 11 de différenciation de croissance activé protéolytiquement stabilisé
|
BR112019015569A2
(pt)
|
2017-01-31 |
2020-03-17 |
Bioverativ Therapeutics Inc. |
Proteínas de fusão do fator ix e métodos para a sua produção e uso
|
SG11202000764RA
(en)
|
2017-08-09 |
2020-02-27 |
Bioverativ Therapeutics Inc |
Nucleic acid molecules and uses thereof
|
BR112020015228A2
(pt)
|
2018-02-01 |
2020-12-29 |
Bioverativ Therapeutics Inc. |
Uso de vetores lentivirais que expressam fator viii
|
WO2019211842A1
(fr)
|
2018-04-30 |
2019-11-07 |
Opko Biologics Ltd. |
Antagonistes de l'hormone de croissance humaine à action prolongée et leurs procédés de production
|
JP2021523878A
(ja)
|
2018-05-18 |
2021-09-09 |
バイオベラティブ セラピューティクス インコーポレイテッド |
血友病aを処置する方法
|
CN108676096B
(zh)
*
|
2018-05-22 |
2022-03-29 |
北京伟杰信生物科技有限公司 |
重组猪fsh-ctp融合蛋白及其制备方法与应用
|
JP2021533753A
(ja)
|
2018-08-09 |
2021-12-09 |
バイオベラティブ セラピューティクス インコーポレイテッド |
核酸分子及び非ウイルス遺伝子治療のためのそれらの使用
|
CA3121786A1
(fr)
|
2018-12-06 |
2020-06-11 |
Bioverativ Therapeutics Inc. |
Utilisation de vecteurs lentiviraux exprimant le facteur ix
|
US11254530B2
(en)
*
|
2019-03-26 |
2022-02-22 |
Toshiba Tec Kabushiki Kaisha |
Sheet aligning mechanism
|
US20220143131A1
(en)
|
2019-05-16 |
2022-05-12 |
Ceva Sante Animale |
Compositions and Methods for increasing Reproduction Performance in Non Human Mammals Using Recombinant Luteinizing Hormone
|
US20210008172A1
(en)
|
2019-07-11 |
2021-01-14 |
Opko Biologics Ltd. |
Long-acting igf-1 or igf-1 variants and methods of producing same
|
EP4038182A1
(fr)
|
2019-09-30 |
2022-08-10 |
Bioverativ Therapeutics Inc. |
Formulations de vecteur lentiviral
|
EP4192495A1
(fr)
|
2020-08-07 |
2023-06-14 |
Bristol-Myers Squibb Company |
Fgf21 combiné à des antagonistes de ccr2/5 pour le traitement de la fibrose
|
US20240123031A1
(en)
|
2020-11-25 |
2024-04-18 |
Bristol-Myers Squibb Company |
Methods of treating liver diseases
|